Healthcare -
Drug Manufacturers - General - NYSE - UK
$ 38.045
1.21 %
$ 77.6 B
Market Cap
24.08
P/E
GSK - COST OF REVENUE
Cost of Revenue GSK - GSK plc
8.56 B
LAST VALUE
-14.08%
2 YEAR CAGR
-3.51%
5 YEAR CAGR
-0.02%
10 YEAR CAGR